<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>TRI OTIC - gentamicin sulfate, betamethasone valerate and clotrimazole ointment </strong><br>Med-Pharmex, Inc<br></p></div>
<h1>GENTAMICIN SULFATE USP, BETAMETHASONE VALERATE, USP, and CLOTRIMAZOLE, USP OINTMENT</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">ANADA #200-229, Approved by FDA<br>VETERINARY<br>For Otic Use in Dogs Only</span></p>
<p><span class="Bold">CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. <br>Keep this and all drugs out of the reach of children.</span></p>
<p><br><span class="Bold">DESCRIPTION:</span> Each gram of gentamicin-betamethasone-clotrimazole ointment contains gentamicin sulfate USP equivalent to 3 mg gentamicin base; betamethasone valerate USP equivalent to 1 mg betamethasone; and 10 mg clotrimazole USP in a mineral oil-based system containing a plasticized hydrocarbon gel.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<p class="First"><span class="Bold">PHARMACOLOGY</span>:<br><span class="Bold">Gentamicin</span>: Gentamicin sulfate is an aminoglycoside antibiotic active against a wide variety of pathogenic gram-negative and gram-positive bacteria. <span class="Italics">In vitro</span> tests have determined that gentamicin is bactericidal and acts by inhibiting normal protein synthesis in susceptible microorganisms. Specifically, gentamicin is active against the following organisms commonly isolated from canine ears: <span class="Italics">Staphylococcus aureus</span>, other <span class="Italics">Staphylococcus</span> spp., <span class="Italics">Pseudomonas aeruginosa</span>, <span class="Italics">Proteus</span> spp., and <span class="Italics">Escherichia coli</span>. <br></p>
<p><span class="Bold">Betamethasone</span>: Betamethasone valerate is a synthetic adrenocorticoid for dermatologic use. Betamethasone, an analog of prednisolone, has a high degree of corticosteroid activity and a slight degree of mineralocorticosteroid activity. Betamethasone valerate, the 17-valerate ester of betamethasone, has been shown to provide anti-inflammatory and anti-pruritic activity in the topical management of corticosteroid-responsive <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span>.  Topical corticosteroids can be absorbed from normal, intact skin. <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">Inflammation</span> can increase percutaneous absorption. Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids.<br><br><span class="Bold">Clotrimazole</span>: Clotrimazole is a broad-spectrum antifungal agent that is used for the treatment of dermal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by various species of pathogenic dermatophytes and yeasts. The primary action of clotrimazole is against dividing and growing organisms.<br><span class="Italics">In vitro</span>, clotrimazole exhibits fungistatic and fungicidal activity against isolates of <span class="Italics">Trichophyton rubrum</span>, <span class="Italics">Trichophyton mentagrophytes</span>, <span class="Italics">Epidermophyton floccosum</span>, <span class="Italics">Microsporum canis</span>, <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span></span> spp. and <span class="Italics">Malassezia pachydermatis</span> (<span class="Italics">Pityrosporum canis</span>). Resistance to clotrimazole is very rare among the fungi that cause superficial mycoses.<br>In an induced <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span> infected with <span class="Italics">Malassezia pachydermatis</span>, 1% clotrimazole in the gentamicin-betamethasone-clotrimazole ointment vehicle was effective both microbiologically and clinically in terms of reduction of exudate odor and <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>.<br>In studies of the mechanism of action, the minimum fungicidal concentration of clotrimazole caused leakage of intracellular phosphorus compounds into the ambient medium with concomitant breakdown of cellular nucleic acids and accelerated potassium efflux. These events began rapidly and extensively after addition of the drug.  Clotrimazole is very poorly absorbed following dermal application.<br><br><span class="Bold">Gentamicin-Betamethasone-Clotrimazole</span>: By virtue of its three active ingredients, gentamicin-betamethasone-clotrimazole ointment has antibacterial, anti-inflammatory, and antifungal activity.<br>In component efficacy studies, the compatibility and additive effect of each of the components were demonstrated. In clinical field trials, gentamicin-betamethasone-clotrimazole was effective in the treatment of <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span> associated with bacteria and <span class="Italics">Malassezia pachydermatis</span>. Gentamicin sulfate USP, Betamethasone valerate, USP and Clotrimazole, USP ointment reduced <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, exudate, and odor, and exerted a strong antimicrobial effect. </p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<p class="First"><span class="Bold">INDICATIONS</span>:  Gentamicin-betamethasone-clotrimazole ointment is indicated for the treatment of canine acute and chronic <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span> associated with yeast (<span class="Italics">Malassezia pachydermatis</span>, formerly <span class="Italics">Pityrosporum canis</span>) and/or bacteria susceptible to gentamicin.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<p class="First"><span class="Bold">CONTRAINDICATIONS</span>: If <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. Concomitant use of drugs known to induce <span class="product-label-link" type="condition" conceptid="4236623" conceptname="Ototoxicity">ototoxicity</span> should be avoided. Do not use in dogs with known perforation of eardrums.</p>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="section-5"></a><p></p>
<p class="First"><span class="Bold">WARNINGS</span>: The use of gentamicin-betamethasone-clotrimazole ointment has been associated with <span class="product-label-link" type="condition" conceptid="377889" conceptname="Hearing loss">deafness</span> or partial <span class="product-label-link" type="condition" conceptid="377889" conceptname="Hearing loss">hearing loss</span> in a small number of sensitive dogs (e.g. geriatric). The hearing deficit is usually temporary. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of gentamicin-betamethasone-clotrimazole ointment immediately and flush the ear canal thoroughly with a non-ototoxic solution.  Corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in <span class="product-label-link" type="condition" conceptid="135923" conceptname="Cleft palate">cleft palate</span> in offspring. Other congenital anomalies including deformed forelegs, <span class="product-label-link" type="condition" conceptid="73307" conceptname="Transverse deficiency of lower limb">phocomelia</span>, and <span class="product-label-link" type="condition" conceptid="4043107" conceptname="Anasarca">anasarca</span> have been reported in offspring of dogs which received corticosteroids during pregnancy.<br>Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, <span class="product-label-link" type="condition" conceptid="4079844" conceptname="Fetal death">fetal death</span>, <span class="product-label-link" type="condition" conceptid="4003030" conceptname="Retained placenta">retained placenta</span>, and metritis.</p>
<p><span class="Bold">PRECAUTIONS</span>: Identification of infecting organisms should be made either by microscopic roll smear evaluation or by culture as appropriate. Antibiotic susceptibility of the pathogenic organism(s) should be determined prior to use of this preparation.<br>If overgrowth of nonsusceptible bacteria, fungi, or yeasts occur, or if <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> develops, treatment should be discontinued and appropriate therapy instituted.<br>Administration of recommended doses of gentamicin-betamethasone-clotrimazole ointment beyond 7 days may result in delayed <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span>-healing.<br>Avoid ingestion. Adverse systemic reactions have been observed following the oral ingestion of some topical corticosteroid preparations. Patients should be closely observed for the usual signs of adrenocorticoid overdosage which include <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span>, potassium loss, <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span>, <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span>, and/or <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>. Prolonged use or overdosage may produce adverse immunosuppressive effects.<br>Use of corticosteroids, depending on dose, duration, and specific steroid, may result in endogenous steroid production inhibition following drug withdrawal. In patients presently receiving or recently withdrawn from corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in especially stressful situations.<br>Before instilling any medication into the ear, examine the external ear canal thoroughly to be certain the tympanic membrane is not ruptured in order to avoid the possibility of transmitting <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> to the middle ear as well as damaging the cochlea or vestibular apparatus from prolonged contact.</p>
</div>
<div class="Section" data-sectionCode="34091-9">
<a name="section-6"></a><p></p>
<p class="First"><span class="Bold">TOXICOLOGY</span>: Clinical and safety studies with Gentamicin sulfate USP, Betamethasone valerate, USP and Clotrimazole USP ointment have shown a wide safety margin at the recommended dose level in dogs (see <span class="Bold">PRECAUTIONS/SIDE EFFECTS</span>). <br></p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<p class="First"><span class="Bold">SIDE EFFECTS</span>: <br><span class="Bold">Gentamicin</span>: While aminoglycosides are absorbed poorly from skin, <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> may occur when aminoglycosides are applied topically for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> of time to large <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span>, <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>, or any denuded skin, particularly if there is <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>. All aminoglycosides have the potential to produce reversible and irreversible vestibular, cochlear and renal toxicity.<br><br><span class="Bold">Betamethasone</span>: Side effects such as SAP and SGPT enzyme elevations, <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span>, and <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span> have occurred following the use of parenteral or systemic synthetic corticosteroids in dogs. <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span> and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> (occasionally bloody) have been observed in dogs and cats.<br>Cushing's syndrome in dogs has been reported in association with prolonged or repeated steroid therapy.<br><br><span class="Bold">Clotrimazole</span>: The following have been reported occasionally in humans in connection with the use of clotrimazole: <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blistering</span>, <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, and general irritation of the skin not present before therapy.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<p class="First"><span class="Bold">DOSAGE AND ADMINISTRATION</span>: The external ear should be thoroughly cleaned and dried before treatment. Remove foreign material, debris, crusted exudates, etc., with suitable non-irritating solutions. Excessive hair should be clipped from the treatment area. After verifying that the eardrum is intact, instill 4 drops (2 drops from the 215 g. bottle) of gentamicin-betamethasone-clotrimazole ointment twice daily into the ear canal of dogs weighing less than 30 lbs.  Instill 8 drops (4 drops from the 215 g. bottle) twice daily into the ear canal of dogs weighing 30 lbs. or more.  Therapy should continue for 7 consecutive days. </p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<p class="First"><span class="Bold">HOW SUPPLIED</span>: Gentamicin-betamethasone-clotrimazole ointment is available in 7.5 gram and 15 gram tubes<br>as well as in 10 gram, 15 gram, 25 gram and 215 gram plastic bottles.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-10"></a><p></p>
<p class="First"><span class="Bold">Store between 2° and 25°C (36° and 77°F).<br>Shake well before use when using the 215 gram bottle.</span></p>
<p><span class="Bold">January 2001</span></p>
<p><span class="Bold">MED-PHARMEX, INC.<br>POMONA, CA 91767</span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<br><div class="Figure"><img alt="Tri Otic 7.5g Tube Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%207.5g%20Tube%20Label.jpg"></div>
<br><div class="Figure"><img alt="Tri Otic 15g Tube Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%2015g%20Tube%20Label.jpg"></div>
<br><div class="Figure"><img alt="Tri Otic 10g Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%2010g%20Label.jpg"></div>
<br><div class="Figure"><img alt="Tri Otic 15g Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%2015g%20Label.jpg"></div>
<br><div class="Figure"><img alt="Tri Otic 25g Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%2025g%20Label.jpg"></div>
<br><div class="Figure"><img alt="Tri Otic 215g Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3&amp;name=Tri%20Otic%20215g%20Label.jpg"></div>
<br><p class="First"><br></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRI OTIC 		
					</strong><br><span class="contentTableReg">gentamicin sulfate, betamethasone valerate,  and clotrimazole  ointment</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PRESCRIPTION ANIMAL DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54925-032</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">AURICULAR (OTIC)</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GENTAMICIN SULFATE</strong> (GENTAMICIN ) </td>
<td class="formItem">GENTAMICIN </td>
<td class="formItem">3 mg  in 1 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>BETAMETHASONE VALERATE</strong> (BETAMETHASONE ) </td>
<td class="formItem">BETAMETHASONE </td>
<td class="formItem">1 mg  in 1 g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CLOTRIMAZOLE</strong> (CLOTRIMAZOLE) </td>
<td class="formItem">CLOTRIMAZOLE</td>
<td class="formItem">10 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54925-032-75</td>
<td class="formItem">7.5 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54925-032-15</td>
<td class="formItem">15 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:54925-032-10</td>
<td class="formItem">10 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:54925-032-45</td>
<td class="formItem">15 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:54925-032-25</td>
<td class="formItem">25 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">6</th>
<td class="formItem">NDC:54925-032-40</td>
<td class="formItem">215 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANADA</td>
<td class="formItem">ANADA200229</td>
<td class="formItem">01/01/2001</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Med-Pharmex, Inc
							(025353699)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2001<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>815eabb5-d5c3-4255-ba34-472d77556e52</div>
<div>Set id: 2cd4866c-30c0-4fd4-9c2b-a019fb2c07a3</div>
<div>Version: 2</div>
<div>Effective Time: 20010101</div>
</div>
</div> <div class="DistributorName">Med-Pharmex, Inc</div></p>
</body></html>
